Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1382) 1382
Paper (663) 663
Publication (512) 512
Report (124) 124
Patent (62) 62
Web Resource (49) 49
Conference Proceeding (48) 48
Book / eBook (45) 45
Book Review (24) 24
Newspaper Article (18) 18
Dissertation (14) 14
Book Chapter (11) 11
Magazine Article (3) 3
Newsletter (3) 3
Reference (2) 2
Data Set (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (709) 709
physics (676) 676
particle physics (653) 653
high energy physics - experiment (628) 628
physics - high energy physics - experiment (601) 601
high energy physics (486) 486
index medicus (365) 365
phenomenology (310) 310
particle physics - experiment (283) 283
humans (273) 273
nuclear experiment (221) 221
physics of elementary particles and fields (219) 219
cern lhc coll (218) 218
experimental results (206) 206
female (204) 204
hep (199) 199
male (159) 159
physical sciences (153) 153
fysik (151) 151
middle aged (150) 150
aged (135) 135
natural sciences (131) 131
naturvetenskap (131) 131
adult (127) 127
scattering [p p] (125) 125
oncology (113) 113
hadron-hadron scattering (108) 108
subatomic physics (107) 107
subatomär fysik (107) 107
atlas (104) 104
astrophysics (102) 102
colliding beams [p p] (102) 102
8000 gev-cms (98) 98
p p: scattering (97) 97
p p: colliding beams (89) 89
high energy astrophysical phenomena (87) 87
physics, particles & fields (85) 85
13000 gev-cms (78) 78
hep-ex (78) 78
article (77) 77
hematology (67) 67
science & technology (67) 67
aged, 80 and over (66) 66
prognosis (64) 64
analysis (63) 63
elementary particles, quantum field theory (63) 63
quantum field theories, string theory (63) 63
animals (62) 62
cancer (57) 57
collisions (54) 54
philosophy (52) 52
abridged index medicus (51) 51
background (50) 50
theology (50) 50
settore fis/01 - fisica sperimentale (49) 49
treatment outcome (49) 49
物理学 (49) 49
large hadron collider (48) 48
research database (48) 48
settore fis/04 - fisica nucleare e subnucleare (48) 48
detectors (47) 47
survival (46) 46
young adult (45) 45
diagnosis (43) 43
research (43) 43
ciências físicas [ciências naturais] (37) 37
performing operations (35) 35
prospective studies (35) 35
transporting (35) 35
adolescent (34) 34
astronomy, astrophysics and cosmology (34) 34
surgery (34) 34
astronomy & astrophysics (33) 33
quantum physics (33) 33
care and treatment (32) 32
chemistry (32) 32
classical and quantum gravitation, relativity theory (32) 32
mice (32) 32
nuclear and high energy physics (32) 32
nuclear energy (32) 32
testing (32) 32
transverse momentum dependence (32) 32
instrumentation and detectors (31) 31
lymphomas (31) 31
mass dependence (31) 31
measurement science and instrumentation (31) 31
microbiology (31) 31
nuclear physics, heavy ions, hadrons (31) 31
chemotherapy (30) 30
data analysis method (30) 30
nuclear and particle physics. atomic energy. radioactivity (30) 30
parton distributions (30) 30
rapidity dependence (30) 30
supersymmetry (30) 30
disease-free survival (29) 29
risk factors (29) 29
identification (28) 28
lhc (28) 28
measuring (28) 28
model (28) 28
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (50) 50
Robarts - Stacks (17) 17
Pontifical Inst. Mediaeval Studies - Library use only (7) 7
St. Michael's College (John M. Kelly) - 3rd Floor (7) 7
Trinity College (John W Graham) - Stacks (7) 7
Regis College - Stacks (5) 5
St. Augustine's Seminary - Stacks (5) 5
UTL at Downsview - May be requested (5) 5
Gerstein Science - Stacks (4) 4
UofT at Mississauga - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Victoria University E.J. Pratt - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
OISE - Stacks (2) 2
Pontifical Inst. Mediaeval Studies - Gilson (2) 2
Pontifical Inst. Mediaeval Studies - Reference (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Trinity College (John W Graham) - Storage (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Earth Sciences (Noranda) - Reference (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Institute for Christian Studies - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Guest (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Reference (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Augustine's Seminary - Missing (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1723) 1723
French (18) 18
German (17) 17
Chinese (3) 3
Japanese (2) 2
Portuguese (2) 2
Italian (1) 1
Korean (1) 1
Latin (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Information sources for science education
by Maurer, Matthew J and ERIC Clearinghouse for Science, Mathematics, and Environmental Education
1998, ERIC digest, Volume EDO-SE-98-08
Science | Study and teaching | Electronic information resources
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Engineering Rhodosporidium toruloides for increased lipid production
by Zhang, Shuyan and Skerker, Jeffrey M and Rutter, Charles D and Maurer, Matthew J and Arkin, Adam P and Rao, Christopher V
Biotechnology and Bioengineering, ISSN 0006-3592, 05/2016, Volume 113, Issue 5, pp. 1056 - 1066
A route to improve lipid production in oleaginous yeast Rhodosporidium toruloides by genetic engineering was developed. As a first step, Zhang and coworkers... 
Agrobacterium tumefaciens | genome sequencing | mediated transformation | lipid production | Rhodosporidium toruloides | biodiesel | Lipid production | Agrobacterium tumefaciens mediated transformation | Genome sequencing | Biodiesel | YEAST YARROWIA-LIPOLYTICA | TRANSFORMATION | SINGLE | SACCHAROMYCES-CEREVISIAE | AGROBACTERIUM-TUMEFACIENS | FATTY-ACID BIOSYNTHESIS | GENE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DNA | ACCUMULATION | CELL OIL PRODUCTION | Transformation, Genetic | Up-Regulation | Metabolic Engineering - methods | Xylose - metabolism | Agrobacterium tumefaciens - genetics | Lipid Metabolism | Basidiomycota - metabolism | Acetyl-CoA Carboxylase - genetics | Diacylglycerol O-Acyltransferase - genetics | Genome, Fungal | Basidiomycota - enzymology | Basidiomycota - genetics | Glucose - metabolism | Diacylglycerol O-Acyltransferase - metabolism | Biofuels - microbiology | Fatty Acids - metabolism | Acetyl-CoA Carboxylase - metabolism | Lipids | Glucose | Genomics | Dextrose | Bioengineering | Yeast | Fatty acids | Index Medicus | Platforms | Organisms | Transformations | Strain
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text POD24 in MZL: a means to an end or an end point in itself?
by Maurer, Matthew J
Blood, 09/2019, Volume 134, Issue 10, pp. 787 - 788
Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text History of autoimmune conditions and lymphoma prognosis
by Kleinstern, Geffen and Maurer, Matthew J and Liebow, Mark and Habermann, Thomas M and Koff, Jean L and Allmer, Cristine and Witzig, Thomas E and Nowakowski, Grzegorz S and Micallef, Ivana N and Johnston, Patrick B and Inwards, David J and Thompson, Carrie A and Feldman, Andrew L and Link, Brian K and Flowers, Christopher and Slager, Susan L and Cerhan, James R
Blood Cancer Journal, ISSN 2044-5385, 08/2018, Volume 8, Issue 8, pp. 73 - 10
Autoimmune conditions are strong risk factors for developing lymphoma, but their role in lymphoma prognosis is less clear. In a prospective cohort study, we... 
RHEUMATOID-ARTHRITIS | B-CELL LYMPHOMA | DISEASES | LIFE-STYLE | ONCOLOGY | NON-HODGKIN-LYMPHOMA | OCCUPATIONAL RISK-FACTORS | SUBTYPES PROJECT | MEDICAL HISTORY | FAMILY-HISTORY | HEMATOLOGY | EPIDEMIOLOGY | T cell receptors | Lymphomas | Health risk assessment | Medical prognosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma
by St‐Pierre, Frédérique and Broski, Stephen M and LaPlant, Betsy R and Ristow, Kay and Maurer, Matthew J and Macon, William R and Habermann, Thomas M and Ansell, Stephen M and Thompson, Carrie A and Micallef, Ivana N. M and Nowakowski, Grzegorz S and Witzig, Thomas E
American Journal of Hematology, ISSN 0361-8609, 07/2019, Volume 94, Issue 7, pp. 786 - 793
Predicting early clinical failure in patients with untreated follicular lymphoma (FL) is important but difficult. This study aimed to determine the incidence... 
Medicine, Experimental | Medical research | Pets | Lymphomas | Prognosis | PET imaging | Spleen | Computed tomography | Multivariate analysis | Lymphoma | Survival
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Loss of TNFAIP3 enhances MYD88 L265P(-) driven signaling in non-Hodgkin lymphoma
by Wenzl, K and Manske, MK and Sarangi, V and Asmann, YW and Greipp, PT and Schoon, HR and Braggio, E and Maurer, MJ and Feldmani, AL and Witzig, TE and Slager, SL and Ansell, SM and Cerhan, JR and Novak, AJ
BLOOD CANCER JOURNAL, ISSN 2044-5385, 10/2018, Volume 8, Issue 10, pp. 1 - 11
MYD88 mutations are one of the most recurrent mutations in hematologic malignancies. However, recent mouse models suggest that MYD88(L265P) alone may not be... 
SURVIVAL | B-CELL LYMPHOMA | ONCOLOGY | INHIBITOR IBRUTINIB | R-CHOP | BCL-2 FAMILY PROTEINS | GENE-EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | WALDENSTROM MACROGLOBULINEMIA | HEMATOLOGY | NF-KAPPA-B | SOMATIC MUTATIONS | Lymphomas | Mutation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma
by Wang, Yucai and Wenzl, Kerstin and Manske, Michelle K and Asmann, Yan W and Sarangi, Vivekananda and Greipp, Patricia T and Krull, Jordan E and Hartert, Keenan and He, Rong and Feldman, Andrew L and Maurer, Matthew J and Slager, Susan L and Nowakowski, Grzegorz S and Habermann, Thomas M and Witzig, Thomas E and Link, Brian K and Ansell, Stephen M and Cerhan, James R and Novak, Anne J
Blood cancer journal, ISSN 2044-5385, 08/2019, Volume 9, Issue 9, pp. 73 - 11
Copy number alterations (CNAs) of 9p24.1 occur frequently in Hodgkin lymphoma, primary mediastinal large B-cell lymphoma (PMBCL), primary central nervous... 
CHOP-LIKE CHEMOTHERAPY | ONCOLOGY | PD-L1 EXPRESSION | GENE-EXPRESSION | BRENTUXIMAB VEDOTIN | CENTRAL-NERVOUS-SYSTEM | YOUNG-PATIENTS | CLASSICAL HODGKIN LYMPHOMA | DEATH LIGAND 1 | HEMATOLOGY | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Gene expression | Immunotherapy | Lymphomas | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
by Thanarajasingam, Gita and Maurer, Matthew J and Habermann, Thomas M and Nowakowski, Grzegorz S and Bennani, N. Nora and Thompson, Carrie A and Cerhan, James R and Witzig, Thomas E
Nutrition and Cancer, ISSN 0163-5581, 10/2018, Volume 70, Issue 7, pp. 1088 - 1090
Dietary factors that may reduce the risk of relapse or prolong remission are an area of interest for patients with cancer. There is little data on the role of... 
RISK | NUTRITION & DIETETICS | EVENT-FREE SURVIVAL | ONCOLOGY | Risk reduction | Lymphoma | Fatty acids | Patients | Diet | Lymphocytes B | Medical prognosis | Biomarkers | Remission | Bioindicators | Lymphomas | Cancer | B-cell lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
by Evanthia Galanis and Kurt A. Jaeckle and Matthew J. Maurer and Joel M. Reid and Matthew M. Ames and James S. Hardwick and John F. Reilly and Andrey Loboda and Michael Nebozhyn and Valeria R. Fantin and Victoria M. Richon and Bernd Scheithauer and Caterina Giannini and Patrick J. Flynn and Dennis F. Moore, Jr and James Zwiebel and Jan C. Buckner
Journal of Clinical Oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2052 - 2058
Purpose Vorinostat, a histone deacetylase inhibitor, represents a rational therapeutic target in glioblastoma multiforme (GBM). Patients and Methods Patients... 
CELLS | HISTONE DEACETYLASE INHIBITOR | IN-VITRO | VIVO | ONCOLOGY | SUBEROYLANILIDE HYDROXAMIC ACID | GLIOMA | GROWTH | MICROARRAYS | EXPRESSION | RADIATION | Prognosis | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Brain Neoplasms - metabolism | Immunoenzyme Techniques | Tissue Distribution | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Adult | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacokinetics | Molecular Structure | Acetylation | Risk Factors | Survival Rate | Treatment Outcome | Neoplasm Recurrence, Local - diagnosis | Brain Neoplasms - drug therapy | Hydroxamic Acids - pharmacokinetics | Glioblastoma - pathology | Hydroxamic Acids - therapeutic use | Aged | Histone Deacetylase Inhibitors | Histones - metabolism | Glioblastoma - drug therapy | Neoplasm Staging | Index Medicus | Original Reports | Neur1 | Bios3
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The potential of serum light chains in diffuse large B-cell lymphoma
by Maurer, Matthew J
Leukemia & Lymphoma, ISSN 1042-8194, 09/2013, Volume 54, Issue 9, pp. 1857 - 1858
SURVIVAL | CHRONIC LYMPHOCYTIC-LEUKEMIA | ONCOLOGY | HEMATOLOGY | POOR | Lymphoma, Large B-Cell, Diffuse - mortality | Immunoglobulin Heavy Chains - blood | Lymphoma, Large B-Cell, Diffuse - blood | Humans | Female | Male | Immunoglobulin Light Chains - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: An analysis from the National LymphoCare Study
by Casulo, Carla and Byrtek, Michelle and Dawson, Keith L and Zhou, Xiaolei and Farber, Charles M and Flowers, Christopher R and Hainsworth, John D and Maurer, Matthew J and Cerhan, James R and Link, Brian K and Zelenetz, Andrew D and Friedberg, Jonathan W
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 23, pp. 2516 - 2522
Purpose Twenty percent of patients with follicular lymphoma (FL) experience progression of disease (POD) within 2 years of initial chemoimmunotherapy. We... 
UNITED-STATES | 1ST-LINE TREATMENT | ONCOLOGY | FREE SURVIVAL | END-POINT | PHASE-III | NON-HODGKINS-LYMPHOMA | RANDOMIZED-TRIAL | R-CVP | STEM-CELL TRANSPLANTATION | WORKING PARTY | United States - epidemiology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Time Factors | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Odds Ratio | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Lymphoma, Follicular - mortality | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Index Medicus | ORIGINAL REPORTS | Hema14
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma
by Matthew T. Drake and Matthew J. Maurer and Brian K. Link and Thomas M. Habermann and Stephen M. Ansell and Ivana N. Micallef and Jennifer L. Kelly and William R. Macon and Grzegorz S. Nowakowski and David J. Inwards and Patrick B. Johnston and Ravinder J. Singh and Cristine Allmer and Susan L. Slager and George J. Weiner and Thomas E. Witzig and James R. Cerhan
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4191 - 4198
Purpose Vitamin D insufficiency is common in the United States, with low levels linked in some studies to higher cancer incidence, including non-Hodgkin's... 
MORTALITY | 25-HYDROXYVITAMIN-D LEVELS | ONCOLOGY | CELL LYMPHOMA | COLORECTAL-CANCER | RISK | HEALTH | INDEX | Prospective Studies | Vitamin D Deficiency - complications | Humans | Middle Aged | Male | Vitamin D Deficiency - mortality | Young Adult | Tandem Mass Spectrometry | Lymphoma, Non-Hodgkin - complications | Time Factors | Vitamin D Deficiency - blood | Lymphoma, Non-Hodgkin - blood | Aged, 80 and over | Chromatography, Liquid | Adult | Female | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Minnesota | Biomarkers - blood | Chi-Square Distribution | Vitamin D - blood | Disease-Free Survival | Iowa | Lymphoma, Non-Hodgkin - therapy | Vitamin D - analogs & derivatives | Aged | Lymphoma, Non-Hodgkin - mortality | Index Medicus | Hema17 | Original Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Abstract 3476: Higher plasma levels of heparan sulfate are associated with improved survival of patients with advanced ovarian cancer
by Block, Matthew S and Maurer, Matthew J and Goergen, Krista M and Erskine, Courtney L and Behrens, Marshall D and Kalli, Kimberly R and Knutson, Keith L
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 3476 - 3476
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Outcomes in refractory diffuse large B-cell lymphoma: Results from the international SCHOLAR-1 study
by Crump, Michael and Neelapu, Sattva S and Farooq, Umar and Van Den Neste, Eric and Kuruvilla, John and Westin, Jason and Link, Brian K and Hay, Annette and Cerhan, James R and Zhu, Liting and Boussetta, Sami and Feng, Lei and Maurer, Matthew J and Navale, Lynn and Wiezorek, Jeff and Go, William Y and Gisselbrecht, Christian
Blood, ISSN 0006-4971, 10/2017, Volume 130, Issue 16, pp. 1800 - 1808
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. Although 5-year survival rates in the first-line setting range from... 
HETEROGENEITY | SURVIVAL | TRANSPLANT-ELIGIBLE PATIENTS | DIAGNOSIS | THERAPY | METAANALYSIS | NON-HODGKINS-LYMPHOMA | SALVAGE-CHEMOTHERAPY | RITUXIMAB ERA | HEMATOLOGY | REGIMENS | Multicenter Studies as Topic - statistics & numerical data | Randomized Controlled Trials as Topic - statistics & numerical data | Humans | Middle Aged | Observational Studies as Topic - statistics & numerical data | Salvage Therapy | Drug Resistance, Neoplasm | Male | Treatment Outcome | International Cooperation | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Lymphoma, Large B-Cell, Diffuse - epidemiology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer
by Galanis, Evanthia and Atherton, Pamela J and Maurer, Matthew J and Knutson, Keith L and Dowdy, Sean C and Cliby, William A and Haluska, Paul and Long, Harry J and Oberg, Ann and Aderca, Ileana and Block, Matthew S and Bakkum-Gamez, Jamie and Federspiel, Mark J and Russell, Stephen J and Kalli, Kimberly R and Keeney, Gary and Peng, Kah Whye and Hartmann, Lynn C
Cancer Research, ISSN 0008-5472, 01/2015, Volume 75, Issue 1, pp. 22 - 30
Edmonston vaccine strains of measles virus(MV) have significant antitumor activity in mouse xenograft models of ovarian cancer. MV engineered to express the... 
PEGYLATED LIPOSOMAL DOXORUBICIN | PHASE-II TRIAL | THERAPY | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | PRIMARY PERITONEAL CANCER | CLINICAL-TRIALS | PLATINUM | CARCINOEMBRYONIC ANTIGEN | EPITOPE POOL | RECURRENT EPITHELIAL OVARIAN | Humans | Middle Aged | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Oncolytic Viruses - genetics | Oncolytic Viruses - metabolism | Xenograft Model Antitumor Assays | Oncolytic Virotherapy - methods | Measles virus - genetics | Animals | Measles virus - metabolism | Ovarian Neoplasms - virology | Symporters - genetics | Oncolytic Viruses - physiology | Ovarian Neoplasms - therapy | Female | Mice | Symporters - biosynthesis | Transgenes | Measles virus - physiology | Cohort Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
by Brian K. Link and Matthew J. Maurer and Grzegorz S. Nowakowski and Stephen M. Ansell and William R. Macon and Sergei I. Syrbu and Susan L. Slager and Carrie A. Thompson and David J. Inwards and Patrick B. Johnston and Joseph P. Colgan and Thomas E. Witzig and Thomas M. Habermann and James R. Cerhan
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3272 - 3278
Purpose This study sought to characterize transformation incidence and outcome for patients with follicular lymphoma (FL) in a prospective observational series... 
SURVIVAL | DIAGNOSIS | ONCOLOGY | REFRACTORY LOW-GRADE | HIGH-DOSE THERAPY | RITUXIMAB | NON-HODGKINS-LYMPHOMA | I-131 TOSITUMOMAB | INDOLENT | HISTOLOGICAL TRANSFORMATION | CHEMOTHERAPY | ORIGINAL REPORTS | Hema10
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Proteolytic and Nonproteolytic Activation Mechanisms Result in Conformationally and Functionally Different Forms of Coagulation Factor XIII A
by Anokhin, Boris A and Dean, William L and Smith, Kerrie A and Flick, Matthew J and Ariëns, Robert A S and Philippou, Helen and Maurer, Muriel C
The FEBS journal, 08/2019
Factor XIIIA (FXIIIA) is a transglutaminase that crosslinks intra- and extracellular protein substrates. FXIIIA is expressed as an inactive zymogen, and during... 
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
: Non-Hodgkin lymphoma in the US 1998-2011
by Al-Hamadani, Mohammed and Habermann, Thomas M and Cerhan, James R and Macon, William R and Maurer, Matthew J and Go, Ronald S
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Non‐Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
by Al‐Hamadani, Mohammed and Habermann, Thomas M and Cerhan, James R and Macon, William R and Maurer, Matthew J and Go, Ronald S
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 790 - 795
The World Health Organization classification of non‐Hodgkin lymphoma (NHL) was introduced in 2001. However, its incorporation into clinical practice is not... 
UNITED-STATES | REVISION | AMERICA | INFLAMMATORY-BOWEL-DISEASE | NEOPLASMS | CLASSIFICATION | T-CELL LYMPHOMA | HEMATOLOGY | WORLD-HEALTH-ORGANIZATION | EPIDEMIOLOGY | United States | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Lymphoma, Mantle-Cell - pathology | Leukemia, Hairy Cell - mortality | Male | Lymphoma, B-Cell, Marginal Zone - mortality | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Lymphoma, Mantle-Cell - mortality | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | B-Lymphocytes - pathology | T-Lymphocytes - pathology | Leukemia, Hairy Cell - pathology | Databases, Factual | Lymphoma, Follicular - pathology | Lymphoma, Follicular - mortality | Terminology as Topic | Burkitt Lymphoma - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Lymphoma, Large-Cell, Anaplastic - mortality | Leukemia, Hairy Cell - diagnosis | Lymphoma, B-Cell, Marginal Zone - diagnosis | Survival Analysis | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Lymphoma, Large-Cell, Anaplastic - pathology | Longitudinal Studies | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Databases | Non-Hodgkin's lymphomas | Native Americans | T cells | Analysis | Leukemia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights